Year: 2022
PRINCETON, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 41st Annual J.P. Morgan Healthcare conference on January 11, 2023 at 7:30pm ET.
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations.
About Integra LifeSciencesIntegra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®,...
Quipt Home Medical Reports Record Fourth Quarter and Fiscal Year 2022 Financial Results Posting Positive Net Income, Revenue Growth of 37% and Adjusted EBITDA Growth of 37%
Written by Customer Service on . Posted in Public Companies.
Posts Strong Adjusted EBITDA Margin of 20.9% for Fiscal Year 2022
CINCINNATI, Dec. 21, 2022 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2022 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2022 and are reported in U.S. Dollars.
Quipt will host its Earnings Conference Call on Thursday, December 22, 2022 at 10:00 a.m. (ET). The dial-in number is 1 (800) 319-4610 or 1 (604) 638-5340. The live audio webcast can be found on the investor section of the Company’s website through the following link: www.quipthomemedical.com.
Financial Highlights:Revenue for fiscal year 2022 was $139.9 million...
Shelter Acquisition Corporation I Announces Determination to Liquidate Company and Delist Before Year-End
Written by Customer Service on . Posted in Public Companies.
NEW YORK, New York, Dec. 21, 2022 (GLOBE NEWSWIRE) — Shelter Acquisition Corporation I (the “Company”) (Nasdaq: SHQA, SHQAU, SHQAW) has announced that, at a special meeting of stockholders held on December 21, 2022, the stockholders approved an amendment to the Company’s amended and restated certificate of incorporation to change the date by which the Company must consummate a business combination from January 2, 2023 to June 30, 2023 or such earlier date as determined by the board of directors of the Company (the “board”) to be in the best interests of the Company (such date, the “Termination Date”).
Because the Company does not believe it will be able to complete an initial business combination by the Termination Date, on December 21, 2022, the board unanimously determined it is in the best interest of the Company to liquidate...
Awilco Drilling PLC: Private Placement completed
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR HONG KONG, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Aberdeen, 21st December 2022
Reference is made to the stock exchange release from Awilco Drilling Plc (“Awilco Drilling” or the “Company”) (Euronext Growth: AWDR) published on 21st December 2021 regarding a contemplated private placement of new Sponsored Norwegian Depository Receipts in the Company up to NOK 78 million (equivalent to USD 8 million) in gross proceeds (the “Private Placement”)
The Company is pleased to announce that the Private Placement has...
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
Written by Customer Service on . Posted in Mergers And Acquisitions.
Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology
Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights Expected as a Standalone Entity
Companies to Host Joint Conference Call and Webcast Today at 5:00 p.m. ET
EMERYVILLE, CA and BRANFORD, Conn., Dec. 21, 2022 (GLOBE NEWSWIRE) — Berkeley Lights (Nasdaq: BLI), a life sciences tools company, and IsoPlexis (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.
The combined company, which will be named PhenomeX (Nasdaq: CELL), will be a premier...
Clear Blue Technologies International Signs Definitive Agreement to Purchase eSite Power Systems with Coincident Private Placement Financing
Written by Customer Service on . Posted in Mergers And Acquisitions.
Acquisition expands product portfolio to larger systems and telecom retrofit market with potential to accelerate timing to cash breakeven
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Dec. 21, 2022 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (“Clear Blue or the Company”) (TSXV:CBLU) announces, signed today, a definitive agreement to acquire all of the outstanding shares of eSite Power Systems AB (“eSite”), a telecom site power systems provider located in Lidköping, Sweden. Once the transaction is completed, eSite will become a wholly owned subsidiary of Clear Blue.
Coincident with the definitive agreement, the Company announces a non-brokered private placement for gross proceeds of up to approximately CAD$2,500,000 (the “Offering”). A first tranche...
Elme Communities to Release Fourth Quarter 2022 Results on Thursday, February 16th
Written by Customer Service on . Posted in Public Companies.
WASHINGTON, Dec. 21, 2022 (GLOBE NEWSWIRE) — Elme Communities (“Elme”) (NYSE:ELME) will release fourth quarter earnings results after market close on Thursday, February 16, 2023.
The conference call will be held on Friday, February 17, 2023, at 10:00 am ET. Conference call access information is as follows:USA Toll Free Number:
888-506-0062International Toll Number:
973-528-0011Entry Code
611448Instant replay of the conference call will be available until Friday, March 3, 2023, at 12:00 am ET. Instant replay access information is as follows:USA Toll Free Number:
877-481-4010International Toll Number:
919-882-2331Conference ID:
47323The live webcast of the conference call will be available on the investor relations page of Elme’s website at www.elmecommunities.com.
About Elme Communities
Elme Communities...
Uniti Group Inc. to Participate at the Citi 2023 Communications, Media & Entertainment Conference
Written by Customer Service on . Posted in Public Companies.
LITTLE ROCK, Ark., Dec. 21, 2022 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Executive Vice President, Chief Technology Officer, Mike Friloux, and Vice President, Finance and Investor Relations, Bill DiTullio, are scheduled to participate at the Citi 2023 Communications, Media & Entertainment Conference on January 4, 2023 in Scottsdale, AZ.
Any written materials relating to the Company’s meetings with investors will be made available on Uniti’s Investor Relations website at investor.uniti.com, starting at 9:00AM EST on January 4, 2023.
ABOUT UNITI
Uniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of fiber and other wireless solutions for the communications...
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program
Written by Customer Service on . Posted in Public Companies.
$259 Million in Equity Securities Sales and $50 Million in Additional Debt Financing Capacity
Madrigal intends to submit a new drug application for resmetirom in the first half of 2023CONSHOHOCKEN, Pa., Dec. 21, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that it has raised $259 million in gross equity (or $255 million in net proceeds) from equity securities issuances and an additional $50 million in liquidity commitments following the achievement of the clinical milestone under its Hercules Credit Facility.
Paul Friedman, M.D., Chief Executive Officer of Madrigal, stated: “The financings secured following the positive topline readout of our Phase 3 MAESTRO-NASH trial reflect the strong support that Madrigal has established with long-standing strategic and institutional investors. The...
Crown Castle to Present at Citi’s 2023 Communications, Media & Entertainment Conference
Written by Customer Service on . Posted in Public Companies.
HOUSTON, Dec. 21, 2022 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today that Dan Schlanger, Crown Castle’s Executive Vice President and Chief Financial Officer, is scheduled to present on Wednesday, January 4, 2023 at 4:30 p.m. Eastern Time at Citi’s 2023 Communications, Media & Entertainment Conference. Mr. Schlanger’s presentation will be broadcast live over the Internet and is expected to last approximately 45 minutes. The live audio webcast link and presentation for the conference will be available on Crown Castle’s website at http://www.crowncastle.com, where it will also be archived for replay.
ABOUT CROWN CASTLE
Crown Castle owns, operates and leases more than 40,000 cell towers and approximately 85,000 route miles of fiber supporting small cells and fiber solutions across...
